CancerOption.com Establishes Scientific Advisory Board; The First Appointment to the Scientific Advisory Board, Dr. James Privitera, M.D.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--June 23, 1999--

CancerOption (OTC BB:CAOP) CancerOption.com, Inc. (Symbol - CAOP) announced today the launch of its Scientific Advisory Board, with the first appointment of Dr. James Privitera, M.D.

Dr. Privitera earned his medical degree at Creighton University and completed his internship in Internal Medicine at Providence Hospital in Seattle, Washington. Following a clinical fellowship in Allergy, Immunology and Rheumatology at Scripps Clinic in La Jolla, CA, Dr. Privitera entered private practice in Covina, California.

Arnold Takemoto, President and CEO of CancerOption.com states, "The goal of the Scientific Advisory Board is to bring effective exposure to the Company through the active participation and counsel of medical professionals. By instituting the Scientific Board, the Company is taking the necessary steps in building the most diverse cancer and immune support portal. I am honored that Dr. James Privitera has joined our board. Dr. Privitera has served on the board of several top health organizations, including the National Health Federation and his experience and expertise will significantly contribute to the Company's mission."

Mr. Takemoto further acknowledges that "CancerOption.com's niche is specifically offering protocols and nutritional supplements that work hand-in-hand in the alternative therapy modality of cancer and immune support. The Company is positioning itself as a leader in the Online Alternative Healthcare Industry. Other Internet industry leaders who have established their niche, such as America Online (NYSE:AOL), Amazon, (Nasdaq:AMZN) and Healtheon Corporation (Nasdaq:HLTH) are perfect examples of the success online companies are achieving."

The Company's mission is to provide a format that educates the general public and physicians on the wide variety of methods to enhance the immune system. In addition to traditional medicine, CancerOption.com will provide insight into complementary therapies and offer nutritional supplements that support the immune system. The Company understands that it is difficult to make educated decisions, especially when one is dealing with the emotional issue of a life threatening disorder. CancerOption.com will present a clear and concise informational stream of content to help educate in all of the various aspects of cancer and immunological disorders.

For more information, please visit our web site at www.canceroption.com

Disclaimer: This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks defined in this document and in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.